Global diabetes technology leader deepens its commitment to Saudi Arabia with a permanent operational base in Riyadh, ...

U.S. growth of 28% was supported by strong type 2 momentum, though results were tempered by higher-than-normal Q1 seasonality related to deductible resets. Management attributes market leadership to a ...

Samsung Galaxy Watch can show compatible CGM glucose data today while Samsung works on future non-invasive blood sugar ...

Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide ...

Good morning, and welcome to the Insulet Corporation First Quarter Earnings Call. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, ...

B.C. has gone from one of the worst public formularies to what I consider to be one of the best. So how did we get here?

Defy Your Genetic Destiny to Live Better, Longer, pioneering endocrinologist Florence Comite, MD, founder of the Center for ...

Insulet’s first quarter was marked by robust revenue growth, driven by continued adoption of its Omnipod 5 insulin delivery ...

Insulet’s latest earnings call carried an upbeat tone, with management emphasizing powerful revenue growth, expanding margins, and a fast-advancing product pipeline. While executives acknowledged ...

Tandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century ...